• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Mid-Morning Market Update: Markets Open Higher; Nasdaq Gains Over 1%

    2/9/22 10:10:46 AM ET
    $CVS
    $CYRN
    $DCFC
    $DOCS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Computer Software: Prepackaged Software
    Technology
    Get the next $CVS alert in real time by email

    US stocks opened on strong note on Wednesday, while the Nasdaq Composite surging more than 1% this morning.

    Following the market opening Wednesday, the Dow traded up 0.77% to 35,736.30 while the NASDAQ rose 1.08% to 14,348.25. The S&P also rose, gaining, 1.06% to 4,569.28.

    Check out this: Executives Buy Around $64M Of 3 Stocks


    Leading and Lagging Sectors


    Materials shares jumped by 1.7% on Wednesday. Meanwhile, top gainers in the sector included Standard Lithium Ltd. (NYSE:SLI), up 9% and FMC Corporation (NYSE:FMC) up 6%.


    In trading on Wednesday, consumer staples shares rose by just 0.2%.


    Top Headline


    CVS Health Corporation (NYSE:CVS) posted better-than-expected results for its fourth quarter.

    CVS Health posted quarterly earnings of $1.98 per share, beating analysts’ estimates of $1.83 per share. The company’s quarterly sales came in at $76.60 billion, versus market expectations of $75.55 billion.

    CVS Health confirmed its FY22 GAAP EPS of $7.04 - $7.24 and adjusted EPS of $8.10 - $8.30, compared to the consensus of $8.28. The company also revised its full-year 2022 cash flow from operations guidance to $12.0 billion - $13.0 billion from $12.5 billion - $13.0 billion.


    Equities Trading UP


    US Ecology, Inc. (NASDAQ:ECOL) shares shot up 69% to $47.47 after Republic Services reported it will buy the company at $48 per share in cash.


    Shares of Tritium DCFC Limited (NASDAQ:DCFC) got a boost, shooting 33% to $12.71. Tritium DCFC shares surged nearly 40% Tuesday after the Australian EV charging company announced its new manufacturing facility will be located in the United States. Tritium CEO Jane Hunter appeared at the White House to make the announcement yesterday.


    Doximity, Inc. (NYSE:DOCS) shares were also up, gaining 24% to $61.97 after the company reported better-than-expected Q3 results and issued FY22 sales guidance above estimates.

    Executives Sell More Than $210M Of 5 Stocks


    Equities Trading DOWN

    QuinStreet, Inc. (NASDAQ:QNST) shares tumbled 32% to $10.61 after the company reported worse-than-expected Q2 adjusted EPS and sales results and cut FY22 guidance. Lake Street downgraded QuinStreet from Buy to Hold.


    Shares of New Relic, Inc. (NYSE:NEWR) were down 26% to $81.24 after the company reported worse-than-expected Q3 adjusted EPS results and issued Q4 and FY22 adjusted EPS guidance below estimates.


    Cyren Ltd. (NASDAQ:CYRN) was down, falling 23% to $3.12. Cyren dropped 14% on Tuesday after the company announced a 1-for-20 reverse split.

    Also check out this: Revelation Biosciences And 3 Other Penny Stocks Bought By Insiders

     

    Commodities

    In commodity news, oil traded down 0.5% to $88.88, while gold traded up 0.1% to $1,828.


    Silver traded up 0.2% Wednesday to $23.235 while copper fell 0.3% to $4.45.



    Euro zone

    European shares were higher today. The eurozone’s STOXX 600 gained 1.5%, London’s FTSE 100 rose 0.5%, while Spain’s IBEX 35 Index rose 1.3%. The German DAX rose 1.6%, French CAC 40 rose 1.5% and Italy’s FTSE MIB Index gained 1.9%.

    Italy’s industrial production fell 1% from a month ago in December. The Germany’s trade surplus shrank to EUR 7 billion in December from EUR 15.1 billion in the year-ago period, while current account surplus narrowed to EUR 23.9 billion from EUR 26.2 billion.


    Economics


    U.S. wholesale inventories rose 2.2% to $789.4 billion in December.


    The Energy Information Administration’s weekly report on petroleum inventories in the U.S. is scheduled for release at 10:30 a.m. ET.


    Federal Reserve Governor Michelle Bowman is set to speak at 10:30 a.m. ET.


    Federal Reserve Bank of Cleveland President Loretta Mester will speak at 12:00 p.m. ET.


    The Treasury is set to auction 10-year notes at 1:00 p.m. ET.

    Also check out: Apple And 3 Other Stocks Sold By Insiders

    Check out the full economic calendar here

    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 78,556,190 cases with around 932,440 deaths. India confirmed a total of at least 42,410,970 cases and 505,300 deaths, while Brazil reported over 26,776,620 COVID-19 cases with 633,890 deaths. In total, there were at least 401,645,060 cases of COVID-19 worldwide with more than 5,784,490 deaths.

    Get the next $CVS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CVS
    $CYRN
    $DCFC
    $DOCS

    CompanyDatePrice TargetRatingAnalyst
    Doximity Inc.
    $DOCS
    2/9/2026$34.00Hold → Buy
    Canaccord Genuity
    Doximity Inc.
    $DOCS
    2/6/2026$40.00Underweight → Neutral
    Analyst
    Doximity Inc.
    $DOCS
    1/20/2026$55.00Equal Weight → Overweight
    Wells Fargo
    Doximity Inc.
    $DOCS
    1/9/2026$59.00Outperform
    RBC Capital Mkts
    Doximity Inc.
    $DOCS
    1/8/2026Hold → Buy
    Truist
    Doximity Inc.
    $DOCS
    12/15/2025$65.00Equal-Weight → Overweight
    Morgan Stanley
    Doximity Inc.
    $DOCS
    12/9/2025$63.00Overweight
    Barclays
    FMC Corporation
    $FMC
    12/9/2025$13.00Equal Weight → Underweight
    Barclays
    More analyst ratings

    $CVS
    $CYRN
    $DCFC
    $DOCS
    SEC Filings

    View All

    SEC Form 13F-HR filed by CVS Health Corporation

    13F-HR - CVS HEALTH Corp (0000064803) (Filer)

    2/13/26 4:07:56 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SCHEDULE 13G filed by Standard Lithium Ltd.

    SCHEDULE 13G - STANDARD LITHIUM LTD. (0001537137) (Subject)

    2/13/26 9:29:46 AM ET
    $SLI
    Major Chemicals
    Industrials

    SEC Form 10-K filed by CVS Health Corporation

    10-K - CVS HEALTH Corp (0000064803) (Filer)

    2/10/26 6:36:59 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $CYRN
    $DCFC
    $DOCS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP and President, Aetna Nelson Steven H bought $1,289 worth of shares (24 units at $53.70) (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    1/27/26 5:20:15 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Raines John Mitchell bought $96,390 worth of shares (7,000 units at $13.77), increasing direct ownership by 103% to 13,784 units (SEC Form 4)

    4 - FMC CORP (0000037785) (Issuer)

    11/14/25 9:19:38 AM ET
    $FMC
    Major Chemicals
    Industrials

    Director Davidson Carol Anthony bought $135,957 worth of shares (10,000 units at $13.60), increasing direct ownership by 76% to 23,227 units (SEC Form 4)

    4 - FMC CORP (0000037785) (Issuer)

    11/7/25 8:36:59 AM ET
    $FMC
    Major Chemicals
    Industrials

    $CVS
    $CYRN
    $DCFC
    $DOCS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CVS Pharmacy Partners with U.S. Soccer Federation and National Women's Soccer League to Promote Community Health and Wellness

    Building on its relationship with the Washington Spirit, CVS expands its commitment to soccer through a new multi-year sponsorship with the league and federation, which includes a national community field investment and partnering with the Kansas City Current and Seattle Reign FCWOONSOCKET, R.I., Feb. 19, 2026 /PRNewswire/ -- CVS Pharmacy® has furthered its commitment to improving community health by becoming an Official Health and Wellness Partner of the U.S. Soccer Federation (USSF) and the National Women's Soccer League (NWSL) and is backing that sponsorship with a multi-year investment to develop community multi‑use soccer fields in select markets across the country.

    2/19/26 9:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health Announces $5 Million Scholarship Program to Support Future Pharmacists in Louisiana

    Investment aims to strengthen the pharmacy workforce and expand access to care across the stateBATON ROUGE, La., Feb. 18, 2026 /PRNewswire/ -- CVS Health® (NYSE:CVS) today announced the launch of a new $5 million scholarship program designed to support aspiring pharmacists in the state of Louisiana. The initiative will provide financial assistance to students pursuing their Doctor of Pharmacy (PharmD) degree at either Xavier University of Louisiana or the University of Louisiana at Monroe. This initiative is part of CVS Health's broader commitment to advancing health equity, exp

    2/18/26 8:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at Bank of America Global Agriculture and Materials Conference

    PHILADELPHIA, Feb. 11, 2026 /PRNewswire/ -- FMC Corporation (NYSE:FMC) today announced that Pierre Brondeau, FMC chairman, chief executive officer and president, and Andrew Sandifer, FMC executive vice president and chief financial officer, will speak at the Bank of America Global Agriculture and Materials conference on February 25, 2026, at 2:45 p.m. Eastern Time. A live webcast will be available at www.fmc.com/investors. About FMC FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC's innovative crop protection solutions – including biologica

    2/11/26 4:30:00 PM ET
    $FMC
    Major Chemicals
    Industrials

    $CVS
    $CYRN
    $DCFC
    $DOCS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Doximity upgraded by Canaccord Genuity with a new price target

    Canaccord Genuity upgraded Doximity from Hold to Buy and set a new price target of $34.00

    2/9/26 6:58:22 AM ET
    $DOCS
    EDP Services
    Technology

    Doximity upgraded by Analyst with a new price target

    Analyst upgraded Doximity from Underweight to Neutral and set a new price target of $40.00

    2/6/26 8:05:27 AM ET
    $DOCS
    EDP Services
    Technology

    Doximity upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Doximity from Equal Weight to Overweight and set a new price target of $55.00

    1/20/26 8:43:16 AM ET
    $DOCS
    EDP Services
    Technology

    $CVS
    $CYRN
    $DCFC
    $DOCS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Interim PFO and PAO Sitaram Siddharth covered exercise/tax liability with 946 shares and was granted 10,376 shares, increasing direct ownership by 14% to 78,733 units (SEC Form 4)

    4 - Doximity, Inc. (0001516513) (Issuer)

    2/18/26 9:54:35 PM ET
    $DOCS
    EDP Services
    Technology

    Chief Financial Officer Bryson Anna was granted 152,258 shares and covered exercise/tax liability with 11,381 shares, increasing direct ownership by 39% to 505,549 units (SEC Form 4)

    4 - Doximity, Inc. (0001516513) (Issuer)

    2/18/26 9:53:26 PM ET
    $DOCS
    EDP Services
    Technology

    Chief Executive Officer Tangney Jeffrey covered exercise/tax liability with 8,243 shares, decreasing direct ownership by 0.37% to 2,232,810 units (SEC Form 4)

    4 - Doximity, Inc. (0001516513) (Issuer)

    2/18/26 9:48:04 PM ET
    $DOCS
    EDP Services
    Technology

    $CVS
    $CYRN
    $DCFC
    $DOCS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Doximity Inc.

    SC 13G/A - Doximity, Inc. (0001516513) (Subject)

    11/14/24 5:22:01 PM ET
    $DOCS
    EDP Services
    Technology

    SEC Form SC 13G filed by Doximity Inc.

    SC 13G - Doximity, Inc. (0001516513) (Subject)

    11/14/24 11:42:53 AM ET
    $DOCS
    EDP Services
    Technology

    SEC Form SC 13G filed by CVS Health Corporation

    SC 13G - CVS HEALTH Corp (0000064803) (Subject)

    11/13/24 1:00:57 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $CYRN
    $DCFC
    $DOCS
    Financials

    Live finance-specific insights

    View All

    CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2025 RESULTS

    Fourth Quarter Highlights Total revenues increased to $105.7 billion, up 8.2% compared to prior yearGAAP diluted EPS of $2.30 and Adjusted EPS of $1.09Full-Year Highlights Total revenues increased to a record high $402.1 billion, up 7.8% compared to prior yearGAAP diluted EPS of $1.39 and Adjusted EPS of $6.75Generated cash flow from operations of $10.6 billionOperational Highlights CVS Pharmacy® successfully completed the transition to cost-based reimbursement across its Commercial, Third-Party Discount, Medicare and Medicaid businesses.Aetna® continues to improve the experience for health care professionals and their patients, approving more than 95% of all eligible prior authorizations wi

    2/10/26 6:30:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    QuinStreet Reports Results for Second Quarter Fiscal 2026

    Record quarterly revenue of $288 million Auto Insurance revenue strong and broadening Continue to expect further margin expansion in 2H FY26 Acquired HomeBuddy in January, significantly expanding Home Services footprint Financial position, balance sheet and cash flow remain strong   QuinStreet, Inc. (NASDAQ:QNST), a leader in performance marketplaces and technologies for the financial services and home services industries, today announced financial results for the fiscal second quarter ended December 31, 2025. For the fiscal second quarter, the Company reported revenue of $287.8 million, up 2% year-over-year. GAAP net income for the fiscal second quarter was $50.2 mill

    2/5/26 4:05:00 PM ET
    $QNST
    Real Estate

    QuinStreet Sets Date to Announce Fiscal Second Quarter 2026 Financial Results

    QuinStreet, Inc. (NASDAQ:QNST), a leader in performance marketplaces and technologies for the financial services and home services industries, today announced it will report financial results for its fiscal second quarter ended December 31, 2025 after the market closes on Thursday, February 5, 2026. On that day, management will hold a conference call and webcast at 2:00 PM PT to review and discuss the company's results. What: QuinStreet Second Quarter 2026 Financial Results Conference Call When: Thursday, February 5, 2026 Time: 2:00 PM PT   Dial in: +1 800-717-1738 (domestic) +1 646-307-1865 (international) Replay In

    1/23/26 8:00:00 AM ET
    $QNST
    Real Estate

    $CVS
    $CYRN
    $DCFC
    $DOCS
    Leadership Updates

    Live Leadership Updates

    View All

    FMC Corporation sets 2026 priorities and announces exploration of strategic options including but not limited to the sale of the company

    Company reports 2025 fourth quarter and full year results, provides 2026 outlook  The organization continues to focus on its 2026 operational priorities, including strengthening the balance sheet, improving the competitiveness of its core portfolio, managing its post-patent Rynaxypyr® active strategy and supporting growth of new active ingredientsThe FMC Board of Directors has authorized the exploration of strategic options, including but not limited to, the sale of the company to unlock shareholder value and ensure its growth and core portfolios are best positioned for long-term success PHILADELPHIA, Feb. 4, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) today announced its 2026 prioritie

    2/4/26 5:00:00 PM ET
    $FMC
    Major Chemicals
    Industrials

    FMC Corporation Reports Third Quarter Results

    Company reports Adjusted EBITDA and Adjusted EPS above guidance midpoints despite lower-than-expected sales Third Quarter 2025 Highlights Revenue of $542 million, down 49 percent versus Q3 2024, impacted by significant one-time commercial actions taken in India to position the business for saleRevenue excluding India of $961 million, down 10 percent versus Q3 2024 (which included India); organic revenue for the period declined 11 percentConsolidated GAAP net loss of $569 million, a decline of $634 million versus Q3 2024, mainly driven by India charges and write-downAdjusted EBITDA of $236 million, up 17 percent versus Q3 2024 (which included India)Consolidated GAAP net loss of $4.52 per dilu

    10/29/25 4:30:00 PM ET
    $FMC
    Major Chemicals
    Industrials

    CVS Health Helps Improve Access to More Affordable Fertility Treatments

    WOONSOCKET, R.I., Oct. 16, 2025 /PRNewswire/ -- CVS Health (NYSE:CVS) today announced it will support simpler access to more affordable fertility treatments for all Americans through its CVS Specialty Pharmacy and make it easier to pick up fertility medication at its 9,000 community pharmacy locations. CVS Specialty Pharmacy will be a core partner in the TrumpRx Fertility program. As the Trump Administration continues to establish more competitive prices for important medicines, the Administration has engaged with EMD Serono, manufacturer of Gonal-F an in-vitro fertilization (

    10/16/25 5:09:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples